Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 17, 2011Journal of Antimicrobial ChemotherapyOpen Access

European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009)

View Full Paper
Ask AI
Bookmark
Share

Authors

NANiels AdriaenssensUniversity of AntwerpSCSamuel CoenenUniversity of AntwerpAVAnn VersportenUniversity of Antwerp

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adriaenssens et al. (2011) studied this question.

synapsesocial.com/papers/6a954d1366ca20f6f97d00cahttps://doi.org/10.1093/jac/dkr457
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adverse drug reactions: implications for the development of fluoroquinolones2003 · 90 citations
  2. 2European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)2011 · 32 citations
  3. 3Fluoroquinolones to treat uncomplicated acute cough in primary care: predictors for unjustified prescribing of antibiotics2010 · 26 citations
  4. 4European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe2011 · 114 citations
  5. 5European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009)2011 · 49 citations